Navigation Links
U of Alberta researchers hoping to stop heart disease in cancer patients before it starts
Date:6/2/2011

Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada.

Ian Paterson, an assistant professor of cardiology at the University of Alberta and Edie Pituskin, a registered nurse and PhD candidate in the Faculty of Rehabilitation Medicine, are starting what is called the MANTICORE clinical trials. Women with breast cancer will be put on heart medication before their cancer treatment.

"Our goal is to look at patients diagnosed with cancer and to detect heart disease and risk factors for heart disease sooner then they're being recognized and treat them aggressively," said Paterson. "We're hoping we can prevent heart disease not only during cancer treatment itself but after the cancer treatment is done."

All patients enrolled in this study must start on the heart disease medication with Paterson and Pituskin prior to treatment.

Paterson and Pituskin decided to start with breast cancer patients because it is the leading cancer in women and the leading cause of cancer deaths in women. Treatments have improved drastically over the years, in particular one pharmaceutical called Herceptin.

"The drug has been shown to really improve survival rates of some types of breast cancer," said Paterson. "Unfortunately it can also damage the heart in up to 20 per cent of women taking this drug.

"We're trying to detect signs of injury much more quickly using special blood tests and special imaging tests like an eco-cardiogram and MRI."

The pair will also try to detect if any of the women involved in the study have cardiac risk factors like high blood pressure and they'll try to treat those very aggressively.

MANTICORE looks to enrol 139 patients, so far 15 are involved in Edmonton and the study is now adding centres in Winnipeg and Toronto. The study is being funded by the Alberta Cancer F
'/>"/>

Contact: Quinn Phillips
quinn.phillips@ualberta.ca
780-248-2048
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Most common cancers in the world decreasing in Alberta: Study
2. Gender-bending fish on the rise in southern Alberta
3. Warning labels better than a fat tax, University of Alberta study shows
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
8. Researchers create drug to keep tumor growth switched off
9. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
10. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
11. Clemson researchers develop hands-free texting application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , ... September 03, 2015 , ... ... and Indiana University, Indianapolis, have chosen Center for Hospice Care (CHC) for ... institutions will train at CHC as part of fulfilling their requirements for obtaining ...
(Date:9/3/2015)... Georgia (PRWEB) , ... September 03, 2015 , ... ... spread of disease in Haiti, has partnered with Slingshot® Product Development Group to ... electricity or running water. Michael Wahl with DriButts plans to bring 600 DriButts ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of a ... Healthcare Research and Policy Analysis has found physician leadership development training programs to ... percent of respondents said their organizations conduct some kind of physician leadership development ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... care community to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado ... 2016, and has been carefully designed to serve up to 80 people living ...
(Date:9/3/2015)... ... September 03, 2015 , ... IQ Formulations ... 2015 by economic development group GrowFL and the Edward Lowe Foundation. The leading ... for this prestigious award, which recognizes growing second-stage companies “that demonstrate high performance ...
Breaking Medicine News(10 mins):Health News:Physicians from Mayo Clinic and Indiana University to Complete Hospice & Palliative Medicine Training at Center for Hospice Care 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3
... , ... skin brightener, has now introduced anti aging ingredients to its already popular product to make ... ... SkinBright the most complete skin brightener available. , , ,Age spots, liver spots, brown patches, ...
... ... to grow, unethical companies are beginning to produce imitation products to benefit from the success ... phony products before they become too large to control. , ... Milford, CT (PRWEB) March 16, 2010 -- They say imitation ...
... ... Marketing Excellence Europe Conference explores how global medical device manufacturers are leveraging integrated, domain-specific ... ... 16, 2010 -- Model N , the leader in Revenue Management solutions for ...
... ... income in the current economy, and who are looking to better their health, too, can ... enlisting interested business leaders nationwide., , ... (PRWEB) March 16, 2010 -- Independent businessman Brad Aspin and leading health and wellness ...
... NANJING , March 16 /PRNewswire-Asia/ -- Simcere Pharmaceutical ... leading pharmaceutical company,specializing in the development, manufacturing, and marketing of ... for the quarter and the fiscal year ended December ... -- Total revenue was RMB539.4 million (US$79.0 million) ...
... Fla. , March 15 ARMSRx ... leader in transparent pharmacy benefits assessment, has received many requests ... the first quarter closes in 2010.  The September 26, ... First DataBank (FDB) and Medispan may very well leave employers ...
Cached Medicine News:Health News:Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients 2Health News:IN Pet Supplements Face Challenges in New China Market as Imitation Products Continue to Baffle Consumers 2Health News:IN Pet Supplements Face Challenges in New China Market as Imitation Products Continue to Baffle Consumers 3Health News:Media Alert: Model N and International Medical Device Leader to Share Insights on Maximizing Sales Performance with Revenue Management 2Health News:Brad Aspin and Health and Wellness Company GBG Now Looking for Leaders Nationwide 2Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 2Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 3Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 4Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 5Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 6Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 7Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 8Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 9Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 11Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 12Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 13Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 14Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 15Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 16Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 17Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 18Health News:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results 19Health News:ARMSRx Evaluation of AWP Neutrality 2Health News:ARMSRx Evaluation of AWP Neutrality 3
(Date:9/3/2015)... YORK , Sept. 3, 2015 About dry ... dryness of eyes due to deficient tear production or ... syndrome is of two types: aqueous tear deficient dry ... dry eye, lacrimal glands do not produce enough tears, ... Meibomian glands secrete lipids to slow tear evaporation and ...
(Date:9/3/2015)... -- As part of its ongoing commitment to provide exceptional ... Katz , MD, MPH, cardiac surgeon and chief medical ... implanted the first HeartMate 3 left ventricular assist device ... part of the prestigious MOMENTUM 3™ Clinical Trial. Bon ... United States—and the first in central Virginia—chosen to evaluate ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Trastuzumab Market, ... by Genentech, trastuzumab was approved by FDA to be ... trade name of Herceptin, a major product of Roche. ... 6.56 billion around the world. After entering ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... Reportlinker.com announces that a new market research report ... Teva Pharma. Industries Ltd: PharmaVitae Profile ... This analysis examines the historical ... pharmaceutical sector. The profile encompasses global company strategy, ...
... Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), ... Zimmer NexGen LPS-Flex Mobile Bearing Knee with ... States.  The LPS-Flex Mobile Bearing knee provides a revolutionary anteriorly-positioned ... (ACL), replicating the anatomic center of knee rotation. ...
Cached Medicine Technology:Reportlinker Adds Teva Pharma. Industries Ltd: PharmaVitae Profile 2Zimmer Introduces a Move Forward in Mobile Bearing Knee Design 2Zimmer Introduces a Move Forward in Mobile Bearing Knee Design 3
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... offer a complete line of ... state-of-the-art monoclonal and monoclonal/polyclonal antibody-based ... of enteric pathogens in fecal ... for Clostridium difficile, Entamoeba histolytica, ...
Inquire...
... CHEK test is a rapid immunoassay to detect ... specimens. The test uses antibodies specific for toxins ... >90% sensitivity and >99% specificity compared to tissue ... and toxin B, the risk of false negative ...
Medicine Products: